Transmedics
TMDX
121 hedge funds and large institutions have $385M invested in Transmedics in 2021 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 42 increasing their positions, 29 reducing their positions, and 23 closing their positions.
45% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 29
2.82% more ownership
Funds ownership: 69.49% → 72.31% (+2.8%)
9% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 23
1% more funds holding
Funds holding: 120 → 121 (+1)
1% less call options, than puts
Call options by funds: $1.35M | Put options by funds: $1.37M
40% less capital invested
Capital invested by funds: $637M → $385M (-$252M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of New York Mellon
New York
|
+$13.4M |
| 2 |
KCM
Kornitzer Capital Management
Shawnee Mission,
Kansas
|
+$11.7M |
| 3 |
SCP
Sandhill Capital Partners
Buffalo,
New York
|
+$9.16M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$4.67M |
| 5 |
HP
Harbourvest Partners
Boston,
Massachusetts
|
+$2.91M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Calamos Advisors
Naperville,
Illinois
|
-$3.91M |
| 2 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
-$2.58M |
| 3 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$2.56M |
| 4 |
Morgan Stanley
New York
|
-$1.82M |
| 5 |
HSBC Holdings
London,
United Kingdom
|
-$1.16M |
TMDX Hedge Fund Activity: Q4 2021 in Review
121 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Transmedics (TMDX) for Q4 2021, worth a combined $385M — down 40% from $637M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new TMDX positions and 23 closed out — a net gain of 2 holders — while 42 added to existing stakes and 29 trimmed.
The largest buyer was Bank of New York Mellon, adding an estimated $13.4M. The largest seller was Calamos Advisors, exiting entirely with an estimated $3.91M sold.
- 121 institutional investors held Transmedics (TMDX) as of Q4 2021, up from 120 in Q3 2021.
- Funds reported $385M of Transmedics stock for Q4 2021, down 40% quarter-over-quarter.
- 25 funds opened new Transmedics positions in Q4 2021 and 23 closed out, a net change of +2 holders.
- The largest Transmedics buyer in Q4 2021 was Bank of New York Mellon, an estimated $13.4M added.
- The largest Transmedics seller in Q4 2021 was Calamos Advisors, an estimated $3.91M sold.
Based on aggregated 13F filings for Q4 2021.